Dealmakers newsletter: March 2008
Welcome to March's edition of the Dealmakers newsletter from CurrentPartnering.
Sponsored by: Intralinks | Verticali | EuroPLX | DMS Data Systems
If not already signed up to receive our newsletters, do so here.
In this issue:
- Editor's corner
- New partnering reports
- In the news - March 2008
- New best practice articles
- Forthcoming events
- Scorecards - updated
- People on the move
- Partnering resources: Software tools
The March issue of Dealmakers is sponsored by:
BioPharm America 2008
BioPharm America is where biotech industry partnerships get started.
Based on the same winning formula used in EBD Group’s distinguished European partnering conferences BIO-Europe and BIO-Europe Spring®, BioPharm America is expected to become the premier stand-alone bio-pharma partnering event in North America. With a clear focus on generating one-to-one meetings for attendees, BioPharm America offers an unrivalled opportunity for participants across the entire biotech value-chain to identify and enter into strategic relationships.
For more information, please log on to http://www.biopharmamerica.com
EDITOR'S CORNER
After a slow start to the year, dealmaking announcements have increased in frequency with bigpharma leading the way.
Most recently Pfizer announced its intention to acquire Serenex, following on from its earlier announcement to acquire Encysive - both deals driven by the opportunity to acqire late stage compounds as well as novel pipelines.
Our latest report Bigpharma Partnering Agreements explores recent trends in bigpharma dealmaking and provides comprehensive access to actual contract documents signed by bigpharma.
The report complements our other recent reports: Merger and Acquisitions Agreements in Biopharma and Co-promotion and Co-marketing Agreements in Biopharma.
You can also view the leading deals so far this year in our Scorecards.
Until next time - happy dealmaking!
- Steve Poile
NEW PARTNERING REPORTS
Bigpharma Partnering Agreements
The Bigpharma Partnering Agreements report provides comprehensive and unprecedented access to the partnering agreements entered into by the worlds leading fifty biopharma companies Bigpharma Partnering Agreements
Merger and Acquisition Agreements in Biopharma
The Merger and Acquisition Agreements in Biopharma report provides comprehensive understanding and unprecedented access to the merger and acquisition (M&A) agreements entered into by the worlds leading biopharma companies Merger and Acquisition Agreements in Biopharma
Co-promotion & Co-marketing Agreements in Biopharma
The Co-promotion and Co-marketing Agreements in Biopharma report provides comprehensive understanding and unprecedented access to the co-promotion and co-marketing partnering agreements entered into by the worlds leading biopharma companies Co-promotion & Co-marketing Agreements in Biopharma
Also:
Practical Guide to Finding Partners in Biopharma
CurrentPartnering’s Practical Guide to Finding Partners in Biopharma provides a comprehensive overview of all the steps required to identify and secure partnering either for an in-licensing or out-licensing activity Practical Guide to Finding Partners in Biopharma
IN THE NEWS
The latest partnering developments - March and February 2008:
- Pfizer to acquire Serenex to extend oncology pipeline
- Crucell in vaccine development agreement with Wyeth
- MicroDose Technologies grants global license to Merck for MicroDose inhaler
- BioWa expands of license agreement with Genentech
- OneWorld Health, Amyris Biotechnologies, and Sanofi-Aventis in development deal for semisynthetic artemisinin
- Merck retains rights to certain AstraZeneca drugs
- Receptor Logic and Sanofi Pasteur to develop T-cell receptor mimics for vaccine research
- Abbott, Genentech and WEHI collaborate to research and develop new anti-cancer drugs
- Baxter Healthcare and Capsule form partnership
- Millipore signs license agreement with Bayer HealthCare
- Pfizer to acquire Encysive and Thelin lung drug
NEW BEST PRACTICE ARTICLES
Research Collaborations: Avoiding Possible Traps
Research collaborations offer institutions the opportunity to achieve goals they might not accomplish on their own: breakthrough discoveries with manageable costs Research Collaborations: Avoiding Possible Traps
Compulsory licenses and access to medicines - Rwanda experience
Rwanda has recently become the first country to make use of the new compulsory licensing provisions that are proposed to form Article 31bis of TRIPs Compulsory licenses and access to medicines - Rwanda experience
FORTHCOMING EVENTS
Here is our suggested partnering events for spring 2008.
Pharmaceutical Strategic Outlook 2008
March 18-20, 2008, The Grand Hyatt New York City, USA
Windhover’s must-attend event examines and explains the most important strategic alliances of the last year, and looks ahead to what the industry can expect in the upcoming year Pharmaceutical Strategic Outlook
BioEurope Spring 2008
April 7-9, 2008, Madrid, Spain
The BIO-Europe Spring event is the premier springtime partnering conference for the biotechnology industry. The inaugural event held in Milan, Italy in March 2007 brought together 1,200 executives representing biotechnology, pharmaceutical and finance companies from 35 countries around the world.
Over a three-day period, delegates engaged in more than 4,000 individual partnering meetings to identify new business opportunities and develop strategic relationships that accelerate their business. The event features the successful combination of one-to-one partnering meetings and company presentations; characteristic of all EBD’s partnering events BioEurope Spring 2008
Impact China IV
Beijing, China, May 4-6, 2008
As the pre-eminent event on the Chinese pharmaceutical market, Impact China IV provides you with the most vital and progressive sessions lead by the foremost experts in the industry Impact China IV
Euro-Biotech Forum 2008
Hotel Arts Barcelona, Barcelona, Spain - May 5-7, 2008
The industry's most exclusive 1:1 partnering meeting for American and European life science companies Euro-Biotech Forum 2008
13th Annual Pharma and Biotech Licensing and Deal Making Summit
New Brunswick, NJ, USA - May 15-16, 2008
Discover new partners, financing and investment options for growth 13th Annual Pharma and Biotech Licensing and Deal Making Summit
SCORECARDS
Our scorecards are updated with the latest deals to break into our most valuable deal rankings - the largest deal for 2008 is Celgene - Acceleron in a $1,900m cancer/metabolic deal. Plus there is the top M&A deal of the year so far between Roche and Ventana.
- Partnering Top 20 - 2008
- Partnering Top 20 - 2007
- Partnering since 2000
- M&A Top 20 - 2008
- M&A Top 20 - 2007
- M&A since 2000
- Bigpharma Top 25 partnering - 2007
PEOPLE ON THE MOVE
The following people have been reported on the move during the weeks of February 2008:
William Ringo, Steven Bloom, Peter Simon, Daniel Bock, Michael Yoshitsu, Eric Karpinski, to name just a few
read more about the latest people on the move
If you have news about a business development executive who is on the move - let us know
PARTNERING RESOURCES: SOFTWARE TOOLS
Numerous software tools exist to support the management and decision making in partnering - software tools
Do you use online partnering websites? Do they offer real benefits? Give us your opinions about Online Partnering here
CurrentPartnering is an online provider of best practice, business information and intelligence for dealmakers
Advertizing and sponsorship
CurrentPartnering offers several advertising options, enabling your product or service to be promoted to our global business development audience - further details available online.
or contact us to discuss your requirements.
Steve Poile, Editor
Web: http://www.CurrentPartnering.com
Mail: Current Partnering, Allanmere House, 6 Hobgate, York, YO24 4HF, United Kingdom
Tel: +44 7896 656732
Fax: +44 8703 305993
Scorecard Index
Deal term reports
The information you provide is excellent and we look forward to doing more business with you in the future
...You have published very timely and interesting materials.... I am excited.... It is an excellent publication and pretty well up to date...
CurrentPartnering Reports
The latest reports on best practise for dealmakers available from CurrentPartnering
Quick links
Term of the week...
Heads of agreement A pre-agreed document that outlines the key elements and structure of the planned deal.